C Capiau

642 total citations
18 papers, 543 citations indexed

About

C Capiau is a scholar working on Epidemiology, Microbiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C Capiau has authored 18 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Microbiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C Capiau's work include Bacterial Infections and Vaccines (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Pneumonia and Respiratory Infections (4 papers). C Capiau is often cited by papers focused on Bacterial Infections and Vaccines (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Pneumonia and Respiratory Infections (4 papers). C Capiau collaborates with scholars based in United States, Belgium and Denmark. C Capiau's co-authors include Philippe M. Hauser, Christiane Feron, David A. Relman, Rino Rappuoli, Anna Prugnola, Vincenzo Scarlato, Stanley Falkow, Mario Domenighini, Yves Lobet and Paul Falmagne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

C Capiau

18 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Capiau United States 12 183 172 158 155 139 18 543
Takehiro Kokuho Japan 16 130 0.7× 210 1.2× 31 0.2× 222 1.4× 152 1.1× 49 731
Maan Zrein Belgium 15 64 0.3× 116 0.7× 97 0.6× 79 0.5× 42 0.3× 32 538
Joakim Westberg Sweden 12 72 0.4× 185 1.1× 191 1.2× 196 1.3× 91 0.7× 14 774
Roderick I. Macfarlan Australia 13 220 1.2× 232 1.3× 125 0.8× 217 1.4× 20 0.1× 17 947
E Simoen Finland 11 98 0.5× 72 0.4× 81 0.5× 66 0.4× 35 0.3× 13 329
Antonella Bartoloni Italy 13 149 0.8× 194 1.1× 524 3.3× 281 1.8× 26 0.2× 17 839
C. Kuyler Doyle United States 12 265 1.4× 354 2.1× 51 0.3× 324 2.1× 502 3.6× 12 891
Patrícia Antônia Estima Abreu Brazil 18 426 2.3× 108 0.6× 64 0.4× 125 0.8× 968 7.0× 42 1.3k
L Syrůcek United States 9 86 0.5× 64 0.4× 45 0.3× 109 0.7× 85 0.6× 33 395
S. Srikumaran United States 13 53 0.3× 270 1.6× 37 0.2× 176 1.1× 46 0.3× 30 552

Countries citing papers authored by C Capiau

Since Specialization
Citations

This map shows the geographic impact of C Capiau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Capiau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Capiau more than expected).

Fields of papers citing papers by C Capiau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Capiau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Capiau. The network helps show where C Capiau may publish in the future.

Co-authorship network of co-authors of C Capiau

This figure shows the co-authorship network connecting the top 25 collaborators of C Capiau. A scholar is included among the top collaborators of C Capiau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Capiau. C Capiau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Capiau, C. (1998). Hepatitis B vaccine.. PubMed. 96. 127–9. 1 indexed citations
2.
Häupl, Thomas, et al.. (1997). Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunology & Medical Microbiology. 19(1). 15–23. 33 indexed citations
3.
Golde, William T., Joseph Piesman, M. C. Dolan, et al.. (1997). Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. Infection and Immunity. 65(3). 882–889. 48 indexed citations
4.
Akkoyunlu, Mustafa, Åsa Melhus, C Capiau, Omer Van Opstal, & Arne Forsgren. (1997). The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infection and Immunity. 65(12). 5010–5016. 19 indexed citations
5.
Bogaerts, H., et al.. (1996). Overview Of The Clinical Development Of A Diphtheria-Tetanus-Acellular Pertussis Vaccine. The Journal of Infectious Diseases. 174(Supplement 3). S276–S280. 9 indexed citations
6.
Gern, Lise, Olivier Rais, C Capiau, et al.. (1994). Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunology Letters. 39(3). 249–258. 35 indexed citations
7.
Cabiaux, Véronique, et al.. (1994). Topology of diphtheria toxin B fragment inserted in lipid vesicies. Molecular Microbiology. 11(1). 43–50. 28 indexed citations
8.
Golde, William T., et al.. (1994). Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A. Infection and Immunity. 62(6). 2625–2627. 32 indexed citations
9.
Conrath, Katja, et al.. (1994). The topology of the S protein in the yeast-derived hepatitis B surface antigen particles.. Journal of Biological Chemistry. 269(41). 25637–25645. 26 indexed citations
11.
Holm, A., et al.. (1992). Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infection and Immunity. 60(10). 3962–3970. 10 indexed citations
12.
Ruuskanen, Olli, Agnès Noël, Anne Putto‐Laurila, et al.. (1991). Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine. 9(2). 117–121. 38 indexed citations
13.
Domenighini, Mario, David A. Relman, C Capiau, et al.. (1990). Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor. Molecular Microbiology. 4(5). 787–800. 96 indexed citations
14.
Francotte, M, et al.. (1989). Monoclonal antibodies specific for pertussis toxin subunits and identification of the haptoglobin-binding site.. Vaccine. 243–247. 11 indexed citations
15.
Locht, Camille, C Capiau, & Christiane Feron. (1989). Identification of amino acid residues essential for the enzymatic activities of pertussis toxin.. Proceedings of the National Academy of Sciences. 86(9). 3075–3079. 33 indexed citations
16.
Pétré, Jean, Philippe M. Hauser, Tineke Rutgers, et al.. (1987). Development of a hepatitis B vaccine from transformed yeast cells.. PubMed. 63 Suppl 2. 73–81. 45 indexed citations
17.
Falmagne, Paul, et al.. (1982). Structure-activity relationships of the B fragment of diphtheria toxin: The lipid-binding domains. Toxicon. 20(1). 243–246. 9 indexed citations
18.
Lambotte, Paul, Paul Falmagne, C Capiau, et al.. (1980). Primary structure of diphtheria toxin fragment B: structural similarities with lipid-binding domains.. The Journal of Cell Biology. 87(3). 837–840. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026